Report overview
This report contains market size and forecasts of Pharma ADMET Testing in Global, including the following market information:
Global Pharma ADMET Testing Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global top five companies in 2022 (%)
The global Pharma ADMET Testing market was valued at million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
In Vivo ADMET Testing Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Pharma ADMET Testing include CMIC Holdings, Charles River Laboratories, WuXi AppTec, Promega Corporation, Merck KGaA, Agilient Technologies, Biovia (Dassault Systemes), Cyprotex Limited and Bio-Rad Laboratories and etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Pharma ADMET Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pharma ADMET Testing Market, by Type, 2018-2023, 2023-2030 ($ millions)
Global Pharma ADMET Testing Market Segment Percentages, by Type, 2022 (%)
In Vivo ADMET Testing
In Vitro ADMET Testing
Global Pharma ADMET Testing Market, by Application, 2018-2023, 2023-2030 ($ millions)
Global Pharma ADMET Testing Market Segment Percentages, by Application, 2022 (%)
Systemic Toxicity Testing
Hepatotoxicity Testing
Renal Toxicity Testing
Neurotoxicity Testing
Others
Global Pharma ADMET Testing Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions)
Global Pharma ADMET Testing Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pharma ADMET Testing revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Pharma ADMET Testing revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
CMIC Holdings
Charles River Laboratories
WuXi AppTec
Promega Corporation
Merck KGaA
Agilient Technologies
Biovia (Dassault Systemes)
Cyprotex Limited
Bio-Rad Laboratories
IQVIA
